Loading…
Niagen Bioscience, Inc. is projected to rise to $3.97 by 2027, a +4% move from its current price of $3.83. NAGE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.72 | $3.83 | $3.95 | +0.01% |
| May 30 | $3.67 | $3.83 | $4.00 | +0.01% |
| May 31 | $3.64 | $3.83 | $4.04 | +0.02% |
| Jun 1 | $3.61 | $3.83 | $4.07 | +0.03% |
| Jun 2 | $3.58 | $3.83 | $4.10 | +0.04% |
| Jun 3 | $3.56 | $3.83 | $4.13 | +0.04% |
| Jun 4 | $3.54 | $3.83 | $4.15 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.54 | $3.83 | $4.15 | +0.05% |
| Week 2 | $3.42 | $3.83 | $4.29 | +0.10% |
| Week 3 | $3.34 | $3.84 | $4.41 | +0.16% |
| Week 4 | $3.27 | $3.84 | $4.50 | +0.21% |
| Week 5 | $3.21 | $3.84 | $4.59 | +0.26% |
| Week 6 | $3.16 | $3.84 | $4.67 | +0.31% |
| Week 7 | $3.11 | $3.84 | $4.75 | +0.36% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Niagen Bioscience, Inc. operates as a bioscience company that develops healthy aging products. It works through Consumer products; Ingredients; and Pharmaceutical Segments, providing finished dietary supplement products that contain proprietary ingredients and the NAD+ coenzyme, which regulates cellular metabolism.
The company commercializes the NAD+ precursor nicotinamide riboside as the flagship NIAGEN ingredient and distributes TRU NIAGEN products directly to consumers via its TRUNIAGEN.com platform, Amazon, and other marketplaces, as well as through specialty retailers and authorized healthcare practitioners resellers. It was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025.
Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
Niagen Bioscience, Inc. (NAGE) is categorized in Healthcare and is currently priced at $3.66 with a market cap of $291.5M, ranking 3558 by market capitalization. These figures place the stock among smaller-cap healthcare names with a focus on NAD+ related health products.
A major floor 27.0% below — a decisive break under it would weaken the trend.
The nearest floor, 4.7% below — buyers have tended to step in here.
The nearest ceiling, 31.1% above — a clean break opens room to run.
A major ceiling 64.0% above — clearing it would confirm fresh momentum.
Key NAGE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NAGE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.78 | Buy | $3.79 | Buy |
| MA 10 | $3.75 | Buy | $3.85 | Sell |
| MA 20 | $4.14 | Sell | $4.05 | Sell |
| MA 50 | $4.43 | Sell | $4.44 | Sell |
| MA 100 | $5.01 | Sell | $5.05 | Sell |
| MA 200 | $6.49 | Sell | $5.94 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.20 | Neutral |
| Stoch RSI (14) | 93.59 | Sell |
| CCI (20) | -47.09 | Neutral |
| Williams %R (14) | -66.67 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -8.15 | Sell |
| Bollinger %B (20,2) | 0.34 | Neutral |
| Stochastic %K (14) | 33.33 | Neutral |
| TRIX (15) | -0.77 | Sell |
| Awesome (5,34) | -0.62 | Sell |
| Ultimate (7,14,28) | 49.15 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 3.81 | Buy |
| ADX (14) | 25.29 | Sell |
| ATR (14) | 0.12 | Info |
Technical sentiment is bearish with an RSI14 of 30. The 50-day simple moving average is $4.47 and the 200-day simple moving average is $6.55. Near-term support is at $3.65 and resistance is at $5.02. The 30-day price range spans from $3.00 to $4.46, illustrating a narrow trading window in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.65 | $3.83 | $4.60 | 0% | Neutral | |
| $3.11 | $3.97 | $5.38 | +4% | Neutral | |
| $2.96 | $3.89 | $5.48 | +2% | Neutral | |
| $2.89 | $3.90 | $5.66 | +2% | Neutral | |
| $3.61 | $4.97 | $7.41 | +30% | Bullish | |
| $3.81 | $5.36 | $8.17 | +40% | Bullish | |
| $3.90 | $5.60 | $8.71 | +46% | Bullish | |
| $3.98 | $5.82 | $9.22 | +52% | Bullish | |
| $3.56 | $5.29 | $8.53 | +38% | Bullish | |
| $3.83 | $5.80 | $9.49 | +51% | Bullish | |
| $5.03 | $8.21 | $14.36 | +114% | Bullish | |
| $8.34 | $15.56 | $29.95 | +306% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.65 | $3.83 | $4.52 | +0.00% |
| June 2026 | $3.35 | $3.95 | $4.76 | +3.06% |
| July 2026 | $3.25 | $3.86 | $4.72 | -2.31% |
| August 2026 | $3.12 | $3.73 | $4.62 | -3.26% |
| September 2026 | $3.12 | $3.76 | $4.70 | +0.85% |
| October 2026 | $3.09 | $3.74 | $4.72 | -0.52% |
| November 2026 | $2.96 | $3.60 | $4.57 | -3.85% |
| December 2026 | $2.94 | $3.60 | $4.60 | +0.05% |
Click any year to see its month-by-month NAGE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NAGE to range from $3.65 to $4.60 through 2026. The $3.83 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The NAGE price prediction for 2027 points to an average of $3.97 (low $3.11, high $5.38) — a potential gain of +4% on today's $3.83. A consolidation phase looks the most probable path here.
In 2028, NAGE is projected to trade between $2.96 and $5.48, averaging $3.89 — a potential gain of +2% from today's $3.83. That is -2% versus the projected 2027 average. Price action looks broadly range-bound.
Niagen Bioscience, Inc.'s 2029 outlook centres on $3.90, within a $2.89 to $5.66 range. That is up 0% on the projected 2028 average. That marks a +2% change versus current levels. A consolidation phase looks the most probable path here.
By 2030, NAGE could reach as high as $7.41, with a base case around $4.97 and support toward $3.61 — roughly +30% from $3.83. Momentum favours further upside here.
Expect NAGE to range from $3.81 to $8.17 through 2031. The $5.36 average target implies a +40% move from current prices. That is up +8% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The NAGE price prediction for 2032 points to an average of $5.60 (low $3.90, high $8.71) — a potential gain of +46% on today's $3.83. Momentum favours further upside here.
In 2033, NAGE is projected to trade between $3.98 and $9.22, averaging $5.82 — a potential gain of +52% from today's $3.83. That is up +4% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Niagen Bioscience, Inc.'s 2034 outlook centres on $5.29, within a $3.56 to $8.53 range. That is -9% versus the projected 2033 average. That marks a +38% change versus current levels. Momentum favours further upside here.
By 2035, NAGE could reach as high as $9.49, with a base case around $5.80 and support toward $3.83 — roughly +51% from $3.83. Buyers look set to stay in control over this stretch.
Expect NAGE to range from $5.03 to $14.36 through 2040. The $8.21 average target implies a +114% move from current prices. That is up +42% on the projected 2035 average. Momentum favours further upside here.
The NAGE price prediction for 2050 points to an average of $15.56 (low $8.34, high $29.95) — a potential gain of +306% on today's $3.83. Buyers look set to stay in control over this stretch.
Investing $1,000 in NAGE today (≈ 261.096606 NAGE) could be worth
$4,063.4
+$3,063.4 (+306%) by 2050 · US Dollar
Based on the average projected NAGE price of $15.56 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NAGEwould be worth at today's price.
$1,000 invested in NAGE on May 27, 2025 (≈ 94.339619 NAGE) would be worth
$361.32
-$638.68 (-63.9%) today · 0.36× · US Dollar
Based on a NAGE entry price of $10.6 vs. today's $3.83.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.75 | $1,021.33 | +2.1% |
| 1 month ago | $4.96 | $772.18 | -22.8% |
| 3 months ago | $5.18 | $739.38 | -26.1% |
| 6 months ago | $6.77 | $565.73 | -43.4% |
| 1 year ago | $10.6 | $361.32 | -63.9% |
| All time (5.0y) ago | $8.38 | $457.04 | -54.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NAGE forecast.
Our base-case forecast reaches $7.70 around 2040.
Implied market cap at $7.70: $613.26M
The multi-year forecast shows a roughly flat to modestly rising near-term trajectory through 2029, with 2026 min $3.65, avg $3.66, max $4.42 (ROI 0%) and 2027 min $2.95, avg $3.76, max $5.09 (ROI 2.6%). 2028 and 2029 continue neutral with avg around $3.64. Beginning in 2030, the outlook turns bullish with 2030 avg $4.59 (max $6.83, ROI 25.4%), 2031 avg $4.94 (ROI 34.9%), 2032 avg $5.18 (ROI 41.5%), 2033 avg $5.34 (ROI 46%), 2034 avg $4.84 (ROI 32.1%), and 2035 avg $5.32 (ROI 45.5%).
The bullish trend extends to 2040 (avg $7.38, max $12.89; ROI 101.8%) and 2050 (avg $13.97, max $26.81; ROI 281.6%). These are estimates and not guarantees, and carry associated upside potential as well as downside risk.
Tap a question to reveal the answer.
2030 min $3.33, avg $4.59, max $6.83; ROI 25.4%; sentiment BULLISH.
Near term shows neutral in 2026 (avg $3.66, ROI 0%), with gradual upside from 2030 onward (2030–2050 forecasts show bullish momentum and higher averages). Keep in mind these are estimates, not guarantees, and reflect volatility and risk.
The forecast includes 2040 max $12.89 and 2050 max $26.81, indicating that moving above $10 is possible within the horizon, though not guaranteed.
Current price $3.66 and market cap $291.5M.
Long-run forecasts show substantial upside under bullish scenarios (2030–2050), but the stock currently carries bearish sentiment and high volatility (annualized volatility 60%), with near-term ranges and mixed returns in 2026–2029.
Niagen Bioscience, Inc. Community Discussion
0Share your Niagen Bioscience, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.